Share of Clicks for top 10 US Pharma & Biotech Pharmacology brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| ro.co | 17.69 |
| lilly.com | 10.71 |
| forbes.com | 7.03 |
| bmimd.com | 5.47 |
| wegovy.com | 3.75 |
| goodlifemeds.com | 3.63 |
| joinamble.com | 3.13 |
| comparetreatments.com | 2.44 |
| ivyrx.com | 2.12 |
| hims.com | 2 |
| others | 42.03 |
- ro.co - 17.69%
- lilly.com - 10.71%
- forbes.com - 7.03%
- bmimd.com - 5.47%
- wegovy.com - 3.75%
- goodlifemeds.com - 3.63%
- joinamble.com - 3.13%
- comparetreatments.com - 2.44%
- ivyrx.com - 2.12%
- hims.com - 2%
- others - 42.03%
Copyright © Adthena. All rights reserved.
In the PPC landscape, ‘ro.co’ leads with 17.69% click share, followed by ‘lilly.com’ at 10.71%. ‘Others’ dominate with 42.03%, showcasing diverse competition.
Share of Spend for the top 10 US Pharma & Biotech Pharmacology brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | ro.co | lilly.com | forbes.com | goodlifemeds.com | bmimd.com | ivyrx.com | joinamble.com | hims.com | comparetreatments.com | citizenmeds.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/07/01 | 22.93% | 13.74% | 7.09% | 0.04% | 0.98% | 0% | 0.29% | 2.36% | 2.87% | 0.02% |
| 2026/07/02 | 22.61% | 10.05% | 6.49% | 0.39% | 0.26% | 0.19% | 1.08% | 1.06% | 4.79% | 0.02% |
| 2026/07/03 | 19.72% | 13.12% | 3.68% | 0.16% | 0.2% | 0.23% | 1.26% | 0.66% | 5.19% | 0.01% |
| 2026/07/04 | 20.7% | 13.1% | 2.81% | 0.24% | 1.58% | 0.7% | 1.39% | 1.25% | 3.18% | 0.49% |
| 2026/07/05 | 21.12% | 8.91% | 3.09% | 0.15% | 0% | 0.24% | 0.72% | 2.15% | 4.36% | 0% |
| 2026/07/06 | 20.84% | 12.13% | 2.28% | 0.43% | 1.04% | 0.15% | 0.58% | 2.65% | 2.99% | 0% |
| 2026/07/07 | 21.51% | 9.19% | 2.35% | 0.15% | 0.25% | 0.27% | 0.83% | 4.46% | 3.33% | 0% |
| 2026/07/08 | 25.38% | 7.9% | 2.7% | 3.15% | 1.31% | 1.44% | 2.02% | 3.63% | 1.82% | 0.91% |
| 2026/07/09 | 24.86% | 10.44% | 2.44% | 1.97% | 4.08% | 2.15% | 1.61% | 3.26% | 2.71% | 0.71% |
| 2026/07/10 | 24.59% | 4.25% | 5.6% | 5.29% | 11.42% | 5.49% | 0.92% | 1.08% | 1.51% | 4.71% |
| 2026/07/11 | 19.91% | 9.43% | 3.21% | 1.59% | 5.51% | 1.93% | 3.55% | 2.11% | 3.14% | 0.6% |
| 2026/07/12 | 20.23% | 8.96% | 8.24% | 2.15% | 5.02% | 2.32% | 3.2% | 1.71% | 3.29% | 1.6% |
| 2026/07/13 | 22.15% | 16.27% | 7.84% | 1.65% | 2.59% | 1.39% | 1.66% | 0.89% | 8.63% | 1.14% |
| 2026/07/14 | 21.52% | 11.15% | 13.99% | 0.09% | 2.71% | 0.19% | 0.67% | 0.59% | 5.76% | 1.87% |
| 2026/07/15 | 30.73% | 10.62% | 5.93% | 4.48% | 1.33% | 3.47% | 1.63% | 1.08% | 2.69% | 0.51% |
| 2026/07/16 | 22.12% | 11.17% | 13.49% | 3.41% | 5.54% | 2.41% | 2.38% | 2.07% | 4% | 1.57% |
| 2026/07/17 | 23.56% | 14.77% | 14.1% | 2.17% | 3.41% | 2.39% | 3.03% | 1.05% | 2.05% | 2.22% |
| 2026/07/18 | 17.98% | 13.03% | 9.14% | 5.78% | 4.23% | 1.51% | 3.51% | 1.9% | 3.02% | 0.82% |
| 2026/07/19 | 17.58% | 11.53% | 7.9% | 7.16% | 11.2% | 4.99% | 4.97% | 2.01% | 1.15% | 0.36% |
| 2026/07/20 | 24.13% | 17.38% | 13.37% | 7.43% | 2.21% | 0.77% | 1.43% | 1.37% | 1.97% | 0.55% |
| 2026/07/21 | 21.49% | 11.14% | 13.97% | 0.09% | 2.71% | 0.19% | 0.66% | 0.59% | 5.76% | 1.87% |
| 2026/07/22 | 24.37% | 10.61% | 4.16% | 5.47% | 8.14% | 2.66% | 3.76% | 3.12% | 4.43% | 3.97% |
| 2026/07/23 | 26.27% | 8.71% | 6.92% | 3.8% | 5.46% | 0.82% | 4.46% | 1.82% | 2.44% | 3.01% |
| 2026/07/24 | 24.64% | 10.4% | 9.43% | 7.01% | 6.89% | 2.62% | 4.7% | 2.45% | 1.54% | 3.15% |
| 2026/07/25 | 20.77% | 7.64% | 10.62% | 5.98% | 4.23% | 4.58% | 6.5% | 2.81% | 5.39% | 2.58% |
| 2026/07/26 | 14.37% | 13.53% | 10.09% | 3.82% | 3.74% | 2.97% | 4.21% | 2.95% | 4.02% | 1.29% |
| 2026/07/27 | 15.43% | 17.19% | 6.57% | 5.39% | 5.54% | 3.64% | 5.84% | 2.06% | 2.09% | 4.96% |
| 2026/07/28 | 18.28% | 13.52% | 8.45% | 7.17% | 10.47% | 2.66% | 3.66% | 1.1% | 1.61% | 4.88% |
| 2026/07/29 | 15.65% | 16.82% | 17.3% | 8.99% | 1.6% | 0.44% | 2.09% | 0.82% | 7.67% | 1.69% |
| 2026/07/30 | 13.95% | 18.41% | 9.81% | 2.6% | 6.67% | 2.99% | 5.2% | 0.97% | 7.39% | 0.66% |
| 2026/07/31 | 22.29% | 10.42% | 7.01% | 6.35% | 4.86% | 3.83% | 3.63% | 3.21% | 3.07% | 2.55% |
- ro.co
- lilly.com
- forbes.com
- goodlifemeds.com
- bmimd.com
- ivyrx.com
- joinamble.com
- hims.com
- comparetreatments.com
- citizenmeds.com
Copyright © Adthena. All rights reserved.
In July 2026, ro.co led with fluctuating spend, peaking at 30.73% mid-month. lilly.com saw a steady rise, ending at 10.42%. forbes.com and goodlifemeds.com showed varied trends, while bmimd.com and ivyrx.com had modest shares. joinamble.com and hims.com maintained low but consistent activity. comparetreatments.com and citizenmeds.com experienced minor fluctuations. The month concluded with ro.co dominating the spend share landscape.
Competitor Count for US Pharma & Biotech Pharmacology
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2026/07/01 | 374 |
| 2026/07/02 | 398 |
| 2026/07/03 | 382 |
| 2026/07/04 | 398 |
| 2026/07/05 | 416 |
| 2026/07/06 | 405 |
| 2026/07/07 | 406 |
| 2026/07/08 | 401 |
| 2026/07/09 | 387 |
| 2026/07/10 | 391 |
| 2026/07/11 | 384 |
| 2026/07/12 | 383 |
| 2026/07/13 | 370 |
| 2026/07/14 | 360 |
| 2026/07/15 | 340 |
| 2026/07/16 | 353 |
| 2026/07/17 | 346 |
| 2026/07/18 | 350 |
| 2026/07/19 | 345 |
| 2026/07/20 | 335 |
| 2026/07/21 | 360 |
| 2026/07/22 | 397 |
| 2026/07/23 | 398 |
| 2026/07/24 | 400 |
| 2026/07/25 | 409 |
| 2026/07/26 | 415 |
| 2026/07/27 | 393 |
| 2026/07/28 | 386 |
| 2026/07/29 | 380 |
| 2026/07/30 | 377 |
| 2026/07/31 | 388 |
Copyright © Adthena. All rights reserved.
July began with 374 advertisers, peaking at 416 mid-month. A dip followed, reaching 335, before rebounding to 388 by month’s end.
